Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Veridion Score
Composite trend over time
Why is SNY moving today?
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for SNY.
SNY insider activity
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for SNY.
SNY contract awards, year to date.
Public federal awards linked to this ticker.
SNY lobbying filings, year to date.
Registered lobbying filings matched to Sanofi American Depositary Shares (Each representing one-half of one ordinary share).